Abstract
A 34-year-old patient with osteogenesis imperfecta (OI) underwent previous double-valve replacement in the aortic and mitral valve position. Bioprostheses were implanted because of an elevated risk of daily injury. Five years later the patient underwent re-replacement of the stenotic stentless mitral valve prosthesis. A right anterolateral mini-thoracotomy was used for operative access during both procedures, in order to preserve thorax stability. Patients with OI may benefit from minimally invasive valve surgery for primary procedures or reoperation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
